Supercharge Your Innovation With Domain-Expert AI Agents!

Oral medicine for treating optic atrophy and retinal arterial obstruction

A technology for retinal artery and optic atrophy, applied in the field of plant and animal materials, can solve problems such as high price, lack of effective traditional Chinese medicine, and vision loss

Inactive Publication Date: 2018-07-10
西安市第四医院
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As the course of the disease progresses, patients may experience severe vision loss or even blindness, causing huge economic and social burdens to patients and their families
[0003] Currently, optic atrophy and retinal artery occlusion are mostly treated with symptomatic adjuvant therapy that nourishes nerves and improves circulation, which is expensive and lacks effective traditional Chinese medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral medicine for treating optic atrophy and retinal arterial obstruction
  • Oral medicine for treating optic atrophy and retinal arterial obstruction
  • Oral medicine for treating optic atrophy and retinal arterial obstruction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Taking the production of 1000 pharmaceutical capsule products of the present invention as an example, the used Chinese medicine raw materials and auxiliary materials and their proportioning ratio are:

[0023]

[0024] Its preparation method is as follows:

[0025] Grind the deicing flakes in the proportion of the present invention into fine powder, and set aside; add water to decoct the other fourteen medicinal materials such as Astragalus membranaceus twice, add 10 times the amount of water for 2 hours for the first time, and add 8 times the amount of water for decoction for the second time Boil for 1.5 hours, filter, combine the filtrates, concentrate to a relative density of 1.10-1.20 (measured at 60°C), add ethanol to make the alcohol content reach 50%, let it stand for 24 hours, take the supernatant, and recover the ethanol under reduced pressure to no alcohol taste, continue to condense into a thick paste, dry, crush, add borneol fine powder, mix well, granula...

Embodiment 2

[0036] Taking the production of 1000 pharmaceutical capsule products of the present invention as an example, the used Chinese medicine raw materials and auxiliary materials and their proportioning ratio are:

[0037]

[0038]

[0039] Its preparation process is identical with the preparation process of embodiment 1 capsule. Each grain weighs 0.4g, and each gram contains 5.636g of traditional Chinese medicine raw materials.

[0040] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used Chinese medicine raw materials and auxiliary materials and their proportioning ratio are:

[0041]

[0042] Its preparation process is carried out according to the preparation process of the tablet of the present invention. Each piece weighs 0.4g, and each gram contains 5.636g of traditional Chinese medicine raw materials.

[0043] Taking the production of pill product 1000g of the present invention as an example, th...

Embodiment 3

[0050] Taking the production of 1000 pharmaceutical capsule products of the present invention as an example, the used Chinese medicine raw materials and auxiliary materials and their proportioning ratio are:

[0051]

[0052]

[0053] Its preparation process is identical with the preparation process of embodiment 1 capsule. Each grain weighs 0.4g, and each gram contains 5.67g of traditional Chinese medicine raw materials.

[0054] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used Chinese medicine raw materials and auxiliary materials and their proportioning ratio are:

[0055]

[0056] Its preparation process is carried out according to the preparation process of the tablet of the present invention. Each piece weighs 0.4g, and each gram contains 5.67g of traditional Chinese medicine raw materials.

[0057] Taking the production of pill product 1000g of the present invention as an example, the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an oral medicine for treating optic atrophy and retinal arterial obstruction. The oral medicine is prepared from the following traditional Chinese medicine raw materials in parts by mass according to the conventional pharmaceutical method: 120-150 parts of radix astragali seu hedysari, 50-80 parts of radix salviae miltiorrhizae, 50-80 parts of semen plantaginis, 50-80 parts of radix rehmanniae preparata, 40-55 parts of fructus broussonetiae, 40-55 parts of semen cuscutae, 40-55 parts of rhizoma chuanxiong, 40-55 parts of radix glehniae, 40-50 parts of fructus lycii, 30-50 parts of fructus leonuri, 30-50 parts of radix ophiopogonis, 30-50 parts of radix angelicae sinensis, 25-30 parts of earthworm, 20-30 pats of fructus schisandrae and 1-5 parts of borneol. The clinical tests prove that the total response rate of the oral medicine provided by the invention for the optic atrophy and the retinal arterial obstruction is obviously higher than that of a control group.

Description

technical field [0001] The invention belongs to the technical field of medical preparations containing raw materials or their reaction products with unknown structures, specifically related to materials derived from plants and animals. Background technique [0002] Optic atrophy and retinal artery occlusion are common fundus lesions that are difficult to treat. As the course of the disease progresses, patients may experience severe vision loss or even blindness, causing huge economic and social burdens to patients and their families. [0003] Currently, optic atrophy and retinal artery occlusion are mostly treated with symptomatic adjuvant therapy that nourishes nerves and improves circulation, which is expensive and lacks effective traditional Chinese medicine. Contents of the invention [0004] The technical problem to be solved by the present invention is to provide a method for improving, maintaining and consolidating retinal circulation for the clinical symptoms and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8968A61P27/02A61P9/10A61P25/00A61K35/62A61K31/045
CPCA61K36/481A61K31/045A61K35/62A61K36/23A61K36/232A61K36/236A61K36/39A61K36/43A61K36/533A61K36/537A61K36/57A61K36/60A61K36/68A61K36/79A61K36/804A61K36/815A61K36/8968A61K2300/00
Inventor 雷晓琴
Owner 西安市第四医院
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com